Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model
about
A comprehensive review of amyotrophic lateral sclerosisNeurotrophic Factors and Their Potential Applications in Tissue Regeneration.Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicineTrophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyStem cells in the nervous systemRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisTherapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative DiseasesA compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functionsRoles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signalingEffect Of combining FK506 and neurotrophins on neurite branching and elongationSafety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cellsTranscriptional profile of muscle following acute induction of symptoms in a mouse model of Kennedy's disease/spinobulbar muscular atrophy.Stem cell therapy for amyotrophic lateral sclerosisExtraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons.Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo.Transgenic GDNF Positively Influences Proliferation, Differentiation, Maturation and Survival of Motor Neurons Produced from Mouse Embryonic Stem Cells.In vivo tracking of human neural progenitor cells in the rat brain using bioluminescence imaging.Current developments in gene therapy for amyotrophic lateral sclerosis.Gene therapy for neurological disorders.The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.Ectopic Muscle Expression of Neurotrophic Factors Improves Recovery After Nerve Injury.Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases.Gene Therapy in the Nervous System: Failures and Successes.Commentary: Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations.Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS.VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.Autocrine production of IGF-I increases stem cell-mediated neuroprotection.Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease.
P2860
Q26775401-C2ECE69F-5AC0-403F-89AE-9121D1A5B475Q26776474-ABBD831B-0EFC-4EE4-9288-DD9B84AED02DQ26863117-8BABF760-A918-41AA-9613-743FB81906ACQ26999881-C05B45E6-716A-423C-9882-D0E1F248BF2BQ27027574-A637ECFD-AB41-439D-88C6-F79D15971516Q27338320-457B5556-5CFF-4560-9F3F-CD4FE5C36192Q27687180-0FA7ED4E-D43A-4F88-A1F4-AD67A917F620Q28067160-D030FDB1-896D-4827-9A93-438A317960E9Q30627872-E6A2F25A-1F8D-48CE-B27C-75BBBD662B7FQ33616384-C1C97621-D89F-47C3-B08C-465CCD81E935Q33870715-9AA30672-ABCE-4CEB-8A83-DC92C04ECC9BQ33918132-1D32B293-4A98-4513-80EF-82DBF8D6893BQ33939595-5A9F2A7D-42CC-42D0-B942-1411CFC43BA7Q35124720-EE24A4C6-5D57-4DEA-A7A6-B1A3D4539AD3Q36301821-7C69AAE4-3AE7-46D4-8CF3-BFC903DD85F8Q36389531-85DDE684-58BE-40C5-9039-161ECF1EB9C7Q36603298-65B9B596-0FFA-478F-A6E2-5B76530BCEABQ36734551-4DE9B8EA-A122-4883-87AC-D54E8491D8DBQ37031363-DFF8AA78-F6B0-41B8-8286-000A23DBE11EQ37158240-624907F5-D553-4A41-9BEC-43B0B85AE8EEQ37246814-2C67E5E6-085B-45F8-B4A2-9C84E904FA63Q37320054-CA6709C6-AB21-48EA-958D-F9F0F8477FAAQ38470242-D609C01B-66AE-4F31-A796-CE20C0D13CFAQ38661071-42F200A0-E9D1-4CFF-9C8F-A24D0B98E0AFQ38701055-5F2FEC0A-C93E-4210-8021-CF4D05DDB616Q38731068-F2E0ABFF-52C7-49B6-8BC4-65FDEC6FD12DQ38834215-6B102EE4-38E8-469B-86B7-6957E52357F6Q39356461-0F0D9EDF-7AD8-4AC1-840B-1A7ACCF2F43AQ40070708-BAF779FF-EEA4-4757-B980-12C14ED178EBQ41139885-E033E195-EF34-482E-BE55-4FC8A945242CQ44704967-FBB806B0-A4DB-43A3-99E8-1F118A0EB745Q45015781-F8396680-6DED-4A65-A8CC-5F2FA6417929Q45857176-21D4B92B-C2C5-4BC8-8F82-F3EC3058D44DQ47152662-C6F148D2-B38B-4037-A6F3-A6C3EAA158C4Q48480002-57FF7B01-A1D4-4FA3-A903-8CDC2CC0D631Q48768631-D6A965D5-0FF3-4A40-ACC4-C1102F4CDC46Q52582224-37866BB6-BD91-4612-9130-2C2D7D0DD55CQ52607614-DEBB92EF-5D94-4837-BC5F-22337C9C56E0Q53655642-84AD3C12-5A68-4A97-B55D-31C43C336321Q53823794-14FC5BB3-F6A0-42C8-8DAE-6161664B3189
P2860
Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergistic effects of GDNF an ...... on in a familial ALS rat model
@en
Synergistic effects of GDNF an ...... n in a familial ALS rat model.
@nl
type
label
Synergistic effects of GDNF an ...... on in a familial ALS rat model
@en
Synergistic effects of GDNF an ...... n in a familial ALS rat model.
@nl
prefLabel
Synergistic effects of GDNF an ...... on in a familial ALS rat model
@en
Synergistic effects of GDNF an ...... n in a familial ALS rat model.
@nl
P2093
P2860
P356
P1433
P1476
Synergistic effects of GDNF an ...... on in a familial ALS rat model
@en
P2093
Chad Zimprich
Christina Lewis
Clive N Svendsen
Dan Krakora
Genevieve Gowing
Ksenija Bernau
Masatoshi Suzuki
Michael Meyer
Patrick Aebischer
P2860
P304
P356
10.1038/MT.2013.108
P577
2013-05-28T00:00:00Z